Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2018-000597-29-FR
EUCTR2018-000597-29-FR
Active, not recruiting
Phase 1

Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis - NPT-MAR

Centre Hospitalier Régional Metz-Thionville0 sites85 target enrollmentMarch 26, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsmite allergenic rhinitisTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Drugs(IMP1)

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
mite allergenic rhinitis
Sponsor
Centre Hospitalier Régional Metz-Thionville
Enrollment
85
Status
Active, not recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 26, 2019
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Centre Hospitalier Régional Metz-Thionville

Eligibility Criteria

Inclusion Criteria

  • •Patient over 18 years old,
  • •Patient with persistent mild to severe or moderate to severe intermittent rhinitis according to ARIA criteria, suspicion of allergic rhinitis to dust mites, and a positive skin test for mites and / or a positive mite specific IgE assay
  • •Patient having signed a free and informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 70
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 15

Exclusion Criteria

  • •Pregnant or breastfeeding women
  • •Patients under guardianship or curatorship
  • •Patients under legal protection
  • •Patients not affiliated to a social security scheme
  • •Contraindications to performing a RNPT
  • •o Active ENT or respiratory infections.
  • •o Allergy in acute phase.
  • •o History of anaphylaxis due to the allergen involved.
  • •o Unstabilized asthma and other obstructive pathologies.
  • •o Severe general illnesses in evolution.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Efficacy of nasal provocation test with VALERGEN-DP, DS and BTAllergic rhinitisRhinitis, AllergicRhinitisNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesImmune System DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivity
RPCEC00000301ational Center of Bioproducts (BioCen)300
Terminated
Phase 4
Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic RhinitisMite AllergyRespiratory Disease
NCT04915352Centre Hospitalier Régional Metz-Thionville8
Not yet recruiting
Not Applicable
The effect of nasal provocation on clinical response and nasal inflammatory parameters in nonallergic rhinitis, mixed rhinitis and allergic rhinitis patients versus healthy individualsnon-allergic rhinitis and non-allergic nasal complaints10046304
NL-OMON32628Academisch Medisch Centrum80
Not yet recruiting
Not Applicable
Effectiveness of nasal prongs in maintaining oxygenation without respiration in patients while giving general anaesthesiaHealth Condition 1: O- Medical and Surgical
CTRI/2020/03/023753Department of AnaesthesiologyNDMC Medical College and Hindu Rao Hospital
Not yet recruiting
Phase 1
Clinical study for the characteristics of nasal and intestinal microflora and the effect of probiotic intervention in people with high exposure to PM2.5
ITMCTR1900002547The Affiliated Hospital of Chengdu University of Traditional Chinese Medicine